VYNE Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.00 M | $1.20 M | 100.00% | 4.68% |
| LYNX1 CAPITAL MANAGEMENT LP | 05/04/2026 | 1.63 M | $973.15 K | 100.00% | 3.81% |
| SHAY CAPITAL LLC | 05/15/2026 | 1.61 M | $962.12 K | -0.87% | 3.77% |
| ANSON FUNDS MANAGEMENT LP | 05/19/2026 | 1.24 M | $742.76 K | -2.45% | 2.91% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 1.06 M | $635.68 K | 319.20% | 2.49% |
| 05/07/2026 | 945.00 K | $564.64 K | 0.00% | 2.21% | |
| BRAIDWELL LP | 05/15/2026 | 916.08 K | $547.36 K | 100.00% | 2.14% |
| CITADEL ADVISORS LLC | 05/15/2026 | 514.44 K | $307.38 K | 1,585.26% | 1.20% |
| 05/13/2026 | 500.55 K | $299.08 K | 0.00% | 1.17% | |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 426.41 K | $254.78 K | 93.82% | 1.00% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 381.80 K | $228.00 K | -40.20% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 322.71 K | $192.82 K | 43.33% | 0.75% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 264.91 K | $158.28 K | 0.00% | 0.62% |
| 05/15/2026 | 264.56 K | $158.21 K | 100.00% | 0.62% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 183.44 K | $109.70 K | 100.00% | 0.43% |
| UBS GROUP AG | 05/05/2026 | 179.78 K | $107.51 K | 186.46% | 0.42% |
| XTX TOPCO LTD | 05/15/2026 | 158.40 K | $94.64 K | 100.40% | 0.37% |
| RANGELEY CAPITAL, LLC | 05/15/2026 | 118.06 K | $70.54 K | 18.06% | 0.28% |
| JANE STREET GROUP, LLC | 05/12/2026 | 95.65 K | $57.15 K | 32.19% | 0.22% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 81.37 K | $48.62 K | 0.00% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 57.78 K | $34.53 K | -42.41% | 0.14% |
| BLACKROCK, INC. | 05/13/2026 | 44.41 K | $26.53 K | 0.00% | 0.10% |
| FNY INVESTMENT ADVISERS, LLC | 04/15/2026 | 35.00 K | $20.00 K | 40.00% | 0.08% |
| HRT FINANCIAL LP | 05/14/2026 | 27.57 K | $16.00 K | 100.00% | 0.06% |
| NORTHERN TRUST CORP | 05/14/2026 | 23.11 K | $13.81 K | 0.00% | 0.05% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 18.30 K | $10.93 K | 0.00% | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 17.30 K | $10.34 K | 100.00% | 0.04% |
| STATE STREET CORP | 05/15/2026 | 15.77 K | $9.42 K | 0.00% | 0.04% |
| HARVEST INVESTMENT SERVICES, LLC | 05/15/2026 | 11.06 K | $6.61 K | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 3.53 K | $2.11 K | -1.12% | 0.01% |
| ACORN CAPITAL ADVISORS, LLC | 05/15/2026 | 1.43 K | $855 | 0.00% | 0.00% |
| MB, LEVIS & ASSOCIATES, LLC | 04/08/2026 | 1.04 K | $622 | 0.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 1.00 K | $600 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 800 | $478 | 0.00% | 0.00% |
| HURLEY CAPITAL, LLC | 05/06/2026 | 561 | $335 | 0.00% | 0.00% |
| CWM, LLC | 05/14/2026 | 500 | $299 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 146 | $86 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 65 | $39 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 43 | $26 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 05/13/2026 | 25 | $15 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/05/2026 | 10 | $6 | 0.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 05/15/2026 | 2 | $1 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VYNE Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 52 institutional investors and hedge funds held shares of VYNE Therapeutics Inc. The most heavily invested institutionals were:
Nantahala Capital Management, LLC: 2 M
Lynx1 Capital Management LP: 1.63 M
Shay Capital LLC: 1.61 M
Anson Funds Management LP: 1.24 M
ADAR1 Capital Management, LLC: 1.06 M
BRAIDWELL LP: 916,077
30.77% of VYNE Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 13.09 M shares in the last 24 months. This purchase volume represents approximately $7.72 M in transactions.